What To Look for In an IRB Provider

Choosing the right Institutional Review Board (IRB) provider is one of the most consequential decisions you’ll make for your clinical trial. The wrong choice can delay your study, create compliance gaps, and ultimately put participants at risk. The right IRB partner, by contrast, accelerates study start-up, reduces administrative burden, and keeps your research on a clear path to regulatory approval. 

This guide outlines the key criteria for evaluating IRB companies — and explains what separates a high-performing commercial IRB from the rest. 

What Is an Independent IRB? 

An independent IRB — also called a central IRB or commercial IRB — is an independent organization that provides ethical review services for clinical trials outside of an academic or institutional setting. Unlike site-based IRBs, independent IRBs can serve as the reviewing body for all sites in multi-site clinical trials, offering broader reach, greater efficiency, and more consistent review standards. 

For multi-site trials in particular, working with an independent IRB can dramatically reduce review timelines and administrative complexity. 

6 Criteria for Evaluating IRB Companies 

Not all independent IRB services are built the same. When comparing IRB providers, evaluate each using these six criteria. 

1. Turnaround Time and Review Speed 

Delays in IRB review directly translate to delays in site activation and patient enrollment. Look for an IRB that consistently delivers full-board review determinations on time, or ahead of schedule. WCG’s full board review takes typically five to eight days, helping sponsors accelerate study start-up without sacrificing rigor. If your study requires an extra level of attention and white-glove service to accelerate processing times without sacrificing quality or integrity, look into WCG’s IRB+ service. 

2. Regulatory Expertise and Compliance Track Record 

Your IRB provider must demonstrate deep, current knowledge of the U.S. federal regulations, Good Clinical Practice (GCP) standards, and applicable international guidelines. Ask prospective IRB companies about their history of FDA audits, their approach to protocol review, and how they stay current as regulations evolve. 

WCG IRB has reviewed over 70,000 protocols since 1998 – underscoring our track record of experience and breadth of review expertise.  

3. Quality Management Systems 

Independent IRBs should operate under formally documented quality management systems. WCG is leading the way in quality-driven research operations by adopting the ISO 9001 standard, strengthening and streamlining our operational processes while reinforcing the rigorous IRB review framework central to our AAHRPP accreditation. 

4. Technology and Workflow Efficiency 

The administrative burden of IRB review is a real cost — in time, resources, and sponsor bandwidth. Evaluate whether a commercial IRB provider offers technology that streamlines submissions, tracks review status, and provides real-time reporting. WCG’s eReview Manager delivers streamlined IRB workflows, reduced administrative burden, and predictable turnaround times through a purpose-built platform. 

5. Experience Across Therapeutic Areas and Study Types 

Specialized trials require reviewers with relevant expertise. Whether you’re running an oncology study, a rare disease program, or a Phase III multi-site trial, your IRB should have demonstrated experience in that space. Central IRB companies with broad portfolios bring pattern recognition and nuanced judgment that newer or narrower providers simply can’t match. 

6. Scope of Support and Integration 

The strongest independent IRB services don’t operate in isolation. They work alongside broader study start-up workflows, site feasibility, and participant recruitment processes. WCG’s Study Accelerator, for example, connects ethical review with site identification and participant recruitment into one coordinated strategy — reducing the handoff friction that so often slows trials down. 

Why WCG Leads Among IRB Companies 

WCG has been the founder and leader of independent ethical review for nearly 60 years. Its scale, systems, and track record distinguish it from other commercial IRB and central IRB companies across every key dimension: 

• Review Speed: WCG’s turnaround time for new protocol determination is less than six days, and less than two days for new site determination.   

• History of Expertise: WCG IRB has reviewed over 70,000 protocols since 1998, demonstrating a track record of trusted review expertise. 

• Certified Quality: WCG is pioneering the adoption of the ISO 9001 standard to improve operational processes in a way that compliments AAHRPP accreditation’s focus on IRB review. 

• Technology-Enabled Review: eReview Manager streamlines workflows and provides real-time reporting. 

• End-to-End Integration: IRB review connects directly to site feasibility, study start-up, and enrollment solutions through the WCG ClinSphere® platform. 

Frequently Asked Questions 

What is the difference between a central IRB and an independent IRB? 

The terms are often used interchangeably. Both refer to IRBs that operate outside of a single institution and provide review services to sponsors, contract research organizations (CROs), and sites across multiple locations. This process helps to standardize review and reduce timelines. While technically any IRB can operate as a central IRB for multi-site studies, independent IRBs are built for this purpose. 

When should a sponsor use a commercial IRB versus an institutional IRB? 

Commercial IRBs are generally preferred for multi-site, multi-jurisdictional studies where consistent review standards and faster turnaround times are priorities. Institutional IRBs may be required or preferred at specific academic sites, but many now accept central IRB review under updated federal regulations. 

How do I know if an IRB company is FDA-compliant? 

Look for IRBs that operate under written standard operating procedures, maintain records of their review activities, and have a verifiable history of regulatory oversight. Credentials such as ISO 9001 certification and AAHRPP accreditation provide additional assurance of quality management. 

What information do I need to submit to a commercial IRB? 

Submissions typically include your protocol, informed consent forms, investigator brochures, recruitment materials, and site information. Requirements vary depending on the study type and regulatory jurisdiction. A strong IRB provider will offer clear submission guidance and a dedicated point of contact to support you through the process. 

How long does IRB review typically take? 

IRB timelines vary by provider and study complexity, but commercial IRBs generally move faster than institutional counterparts. WCG’s turnaround time for new protocol determination is less than six days and less than two days for new site determination. 

Work with the IRB Trusted by 94% of FDA-Approved Trials 

Selecting the right IRB isn’t just a compliance decision — it’s a strategic one. WCG combines unmatched regulatory expertise, proven technology, and nearly 60 years of ethical review leadership to help your trial move forward with confidence.  

Whether you’re planning a first-in-human study, managing a complex multi-site trial, or seeking help with the IRB submission process, WCG is ready to support you. Fill in your information below for a free ethical review consultation or for answers to your IRB review questions.